The Genetic Landscape and Clonal Evolution of Breast Cancer Resistance to Palbociclib plus Fulvestrant in the PALOMA-3 Trial (2018)
Attributed to:
MICA: Using circulating tumour DNA to identify and predict mechanisms of resistance to targeted cancer therapies.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/2159-8290.cd-18-0264
PubMed Identifier: 30206110
Publication URI: http://europepmc.org/abstract/MED/30206110
Type: Journal Article/Review
Parent Publication: Cancer Discovery
Issue: 11
ISSN: 2159-8274